We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

August 10, 2018

Clinical view on adherence tracking devices

Commentary
Julie Carty

We recently completed an interview with Peter Chai, an MD and Medical Toxicology Fellow at the University of Massachusetts, Toxicologist and primary author of numerous publications on digital health studies. Focusing on the clinical perspective, we captured Peter's insights on the following questions.

Which solutions do you see delivering the greatest impact on improving medication adherence?

Measuring Adherence is Difficult Current measures of adherence rely on patient feedback through self-reporting, pharmacy prescription refills and advancing technology like smart pill bottles. These measures of adherence have varying levels of accuracy, and indirectly measure adherence in aggregate. Adherence data is difficult to interpret – how sure can you be for oral medication that the opening of a smart pill cap/box correlates with the patient actually taking the medication. Digital Pills Deliver the Greatest Impact Digital pills provide direct, real-time measures of adherence by monitoring true ingestion events. Medications coupled with an ingestible biosensor that activates only upon contact with the stomach ensures that remote signals of adherence are true. Not only does this improve upon the quality of the data, but ingestible biosensing allows for detection of nascent episodes of non-adherence, allowing clinicians to intervene before behaviors associated with nonadherence become ingrained.

How do you see devices like these incorporating into your daily consults?

As an emergency medicine physician, ingestible biosensors can be used to improve home care, assess post-discharge, discover medication ingestion patterns and help ensure patients adhere to their medication regimens. Real-time medication adherence data already enhances my consultant process with patients. I can address irregularities with prescription patterns at an early stage and without over-reliance on subjective data from patients. The application of smart technology to monitor adherence will only increase. The question is in what form? In a younger tech-savvy population, apps and connected devices will gain traction. In older populations we will need to rely more on passive monitoring and interventions.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

No upcoming Virtual Events scheduled. Please check back again soon.

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

30TH APRIL 2024 @ 11AM ET

Tech-Enabled Health in Cardiovascular Disease

The integration of technology in cardiovascular disease (CVD) management holds significant potential for pharma and healthcare alike.

Caroline György
Featuring
Caroline György
COO, Exploris Health AG
2nd May 2024 @ 11am ET

Redesigning Patient Experiences: Infusion Therapies

In the ever-evolving landscape of healthcare, the focus on patient-centricity has become increasingly paramount.
Torben Nielsen
Featuring
Torben Nielsen
CEO and Co-Founder, Uptiv Health
7th May 2024 @ 11am ET

Game Changer? DTx on Drug Labels

The digital therapeutics market has experienced fluctuations, but a potential turning point has emerged with the release of new FDA guidance.
Shaheen Lakhan
Featuring
Shaheen Lakhan
Chief Medical Officer , Click Therapeutics

Beliefs that are Holding Digital Health Back

Please bear with us. This meeting is under construction, details will follow shortly.
Featuring

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.